This investigation compares the effects of three farnesyl pyrophosphat
e analogs on selected aspects of isoprenoid metabolism. E,E-alpha-Hydr
oxyfarnesylphosphonate was prepared by an improved variation on a lite
rature synthesis, which also gave access to the new Z,E-alpha-hydroxyf
arnesyl- and alpha-hydroxygeranylphosphonates. A striking find is that
only E,E-alpha-hydroxyfarnesylphosphonate induces alteration of RAS p
rocessing in intact human-derived leukemia cells and inhibits farnesyl
protein transferase in enzyme assays, while the Z,E-alpha-farnesyl- a
nd geranylphosphonates are inactive. The inhibitory activity of E,E-al
pha-hydroxyfarnesylphosphonate is greater in enzyme than intact cell a
ssays. This active compound does not significantly inhibit geranylgera
nyl protein transferase I or squalene synthase, nor does it diminish c
holesterol synthesis. These results indicate that the length of the te
rpenoid chain and olefin stereochemistry allow selective inhibition of
critical enzymes of terpenoid metabolism. Discrimination was observed
between inhibition of farnesyl protein transferase and squalene synth
ase by E,E-alpha-hydroxyfarnesylphosphonate, even though both enzymes
utilize farnesyl pyrophosphate as their natural substrate.